Moreover, a novel study found that glucagon-like peptide-1 receptor (GLP1R) agonists can block the conversion of trophic to A1 astrocytes, suggesting that Diabetes mellitus type 2 treatments, including liraglutide, may benefit inflammaging and AD (46). The gene discussed is GLP1R; the disease is Alzheimer disease.